miR-499 Ameliorates Podocyte Injury by Targeting Calcineurin in Minimal Change Disease

Conclusions: MiR-499 ameliorated podocyte injury by targeting CnA α and CnAβ in a PAN-induced MCD mouse model. Delivery of miR-499 can be a novel strategy for MCD treatment.Am J Nephrol 2018;47:94 –102
Source: American Journal of Nephrology - Category: Neurology Source Type: research